KEY FACTORS FOR SUCCESSFUL GENERATION OF PROTEIN-FRAGMENT STRUCTURES: REQUIREMENT ON PROTEIN, CRYSTALS, AND TECHNOLOGY

被引:14
作者
Boettcher, Jark [1 ]
Jestel, Anja [1 ]
Kiefersauer, Reiner [1 ]
Krapp, Stephan [1 ]
Nagel, Susanna [1 ]
Steinbacher, Stefan [1 ]
Steuber, Holger [1 ]
机构
[1] Proteros Biostruct GmbH, Martinsried, Germany
来源
FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES | 2011年 / 493卷
关键词
X-RAY CRYSTALLOGRAPHY; STRUCTURE-BASED DESIGN; TYROSINE-PHOSPHATASE; 1B; NITRIC-OXIDE SYNTHASE; LEAD DISCOVERY; DRUG DESIGN; BETA-SECRETASE; KINASE INHIBITORS; LIGAND-BINDING; ACTIVE-SITE;
D O I
10.1016/B978-0-12-381274-2.00003-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the past two decades, fragment-based approaches have evolved as a predominant strategy in lead discovery. The availability of structural information on the interaction geometries of binding fragments is key to successful structure-guided fragment-to-lead evolution. In this chapter, we illustrate methodological advances for protein fragment crystal structure generation in order to offer general lessons on the importance of fragment properties and the most appropriate crystallographic setup to evaluate them. We analyze elaborate protocols, methods, and clues applied to challenging complex formation projects. The results should assist medicinal chemists to select the most promising targets and strategies for fragment-based crystallography as well as provide a tutorial to structural biologists who attempt to determine protein-fragment structures.
引用
收藏
页码:61 / 89
页数:29
相关论文
共 102 条
  • [81] Fragment-based lead discovery
    Rees, DC
    Congreve, M
    Murray, CW
    Carr, R
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 660 - 672
  • [82] PURIFICATION AND CRYSTALLIZATION OF HUMAN CYCLIN-DEPENDENT KINASE-2
    ROSENBLATT, J
    DEBONDT, H
    JANCARIK, J
    MORGAN, DO
    KIM, SH
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (04) : 1317 - 1319
  • [83] Identification of inhibitors of protein kinase B using fragment-based lead discovery
    Saxty, Gordon
    Woodhead, Steven J.
    Berdini, Valerio
    Davies, Thomas G.
    Verdonk, Marcel L.
    Wyatt, Paul G.
    Boyle, Robert G.
    Barford, David
    Downham, Robert
    Garrett, Michelle D.
    Carr, Robin A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) : 2293 - 2296
  • [84] Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: A critical view of the relevance of in vitro metalloenzyme assays
    Schiffmann, R
    Heine, A
    Klebe, G
    Klein, CDP
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (23) : 3620 - 3623
  • [85] Thermodynamic Optimisation in Drug Discovery: A Case Study using Carbonic Anhydrase Inhibitors
    Scott, Andrew D.
    Phillips, Chris
    Alex, Alexander
    Flocco, Maria
    Bent, Andrew
    Randall, Amy
    O'Brien, Ronan
    Damian, Luminita
    Jones, Lyn H.
    [J]. CHEMMEDCHEM, 2009, 4 (12) : 1985 - 1989
  • [86] Structural analysis of NSAID binding by prostaglandin H2 synthase:: Time-dependent and time-independent inhibitors elicit identical enzyme conformations
    Selinsky, BS
    Gupta, K
    Sharkey, CT
    Loll, PJ
    [J]. BIOCHEMISTRY, 2001, 40 (17) : 5172 - 5180
  • [87] A short history of SHELX
    Sheldrick, George M.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : 112 - 122
  • [88] Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions
    Sichler, K
    Banner, DW
    D'Arcy, A
    Hopfner, KP
    Huber, R
    Bode, W
    Kresse, GB
    Kopetzki, E
    Brandstetter, H
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2002, 322 (03) : 591 - 603
  • [89] High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group
    Steuber, H
    Zentgraf, M
    Podjarny, A
    Heine, A
    Klebe, G
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2006, 356 (01) : 45 - 56
  • [90] Stubbs MT, 2002, CHEMBIOCHEM, V3, P246, DOI 10.1002/1439-7633(20020301)3:2/3<246::AID-CBIC246>3.0.CO